لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Khanh T. Do, Claire F. Friedman, François-Clément Bidard, Richard Bryce, Anishka D'souza, Bradley J. Monk, Adam C. ElNaggar, Lynda D. Roman, Feng Xu, Irene Brana, Kiana Keyvanjah, Edwin A. Alvarez, Funda Meric-Bernstam, Rodolfo Passalacqua, David M. Hyman, Valentina Boni, David B. Solit, Ana Oaknin, Alessandro D. Santin, Jonathan H. Goldman, Lisa D. Eli, Alshad S. Lalani

المساهمون: Institut Català de la Salut, [Oaknin A, Brana I] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Friedman CF] Memorial Sloan Kettering Cancer Center, New York, NY, USA. [Roman LD, D'Souza A] USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA. [Bidard FC] Institut Curie, St Cloud, France, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
Gynecologic oncology
Gynecologic oncology, vol 159, iss 1

مصطلحات موضوعية: 0301 basic medicine, Oncology, Receptor, ErbB-2, Neratinib, Administration, Oral, Uterine Cervical Neoplasms, Tyrosine kinase inhibitor, Kaplan-Meier Estimate, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Severity of Illness Index, Tyrosine-kinase inhibitor, ErbB-2, 0302 clinical medicine, Clinical endpoint, 6.2 Cellular and gene therapies, Cancer, Cervical cancer, Obstetrics and Gynecology, Nausea, Middle Aged, Progression-Free Survival, Clinical trial, Diarrhea, Local, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Administration, Quinolines, Female, medicine.symptom, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias del cuello uterino [ENFERMEDADES], Receptor, medicine.drug, Oral, Adult, medicine.medical_specialty, medicine.drug_class, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Uterine Cervical Neoplasms [DISEASES], Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [CHEMICALS AND DRUGS], Article, Paediatrics and Reproductive Medicine, Coll uterí - Càncer - Tractament, 03 medical and health sciences, Clinical Research, Internal medicine, medicine, Humans, Oncology & Carcinogenesis, Adverse effect, Protein Kinase Inhibitors, Response Evaluation Criteria in Solid Tumors, business.industry, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas [COMPUESTOS QUÍMICOS Y DROGAS], medicine.disease, Proteïnes quinases - Inhibidors, Neoplasm Recurrence, 030104 developmental biology, Mutation, Neoplasm Recurrence, Local, business, HER2 mutant

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::188b242a6feeedb6adbc71f9d83353ba
https://hdl.handle.net/11351/6338

المؤلفون: Rios-Doria E; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Abu-Rustum NR; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of OB/GYN, Weill Cornell Medical College, New York, New York, USA., Alektiar KM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Makker V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Liu YL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Zamarin D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Friedman CF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Ellenson LH; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Chiang S; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Mueller JJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of OB/GYN, Weill Cornell Medical College, New York, New York, USA., Leitao MM; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA leitaom@mskcc.org.; Department of OB/GYN, Weill Cornell Medical College, New York, New York, USA.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 May 23. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

المؤلفون: Friedman CF; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. friedmac@mskcc.org.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. friedmac@mskcc.org.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA. friedmac@mskcc.org., Manning-Geist BL; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhou Q; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Soumerai T; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Holland A; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Da Cruz Paula A; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Green H; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ozsoy MA; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Iasonos A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hollmann T; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leitao MM Jr; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA., Mueller JJ; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA., Makker V; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Tew WP; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., O'Cearbhaill RE; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Liu YL; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Rubinstein MM; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Troso-Sandoval T; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Lichtman SM; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Schram A; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Kyi C; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Grisham RN; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Causa Andrieu P; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wherry EJ; Institute of Immunology,University of Pennsylvania, Philadelphia, PA, USA., Aghajanian C; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hensley ML; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Zamarin D; Tisch Cancer Institute,Icahn School of Medicine at Mount Sinai, New York, NY, USA. dmitriy.zamarin@mssm.edu.

المصدر: Nature medicine [Nat Med] 2024 May; Vol. 30 (5), pp. 1330-1338. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Nivolumab*/therapeutic use , Nivolumab*/adverse effects , Biomarkers, Tumor*/genetics , DNA Mismatch Repair*/genetics, Humans ; Female ; Middle Aged ; Aged ; Adult ; Genital Neoplasms, Female/drug therapy ; Genital Neoplasms, Female/genetics ; Genital Neoplasms, Female/pathology ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Progression-Free Survival ; Aged, 80 and over ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Mutation ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/genetics ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Agents, Immunological/adverse effects

المؤلفون: Sia TY; Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wan V; Obstetrics & Gynecology, Brooklyn Hospital Center, Brooklyn, New York, USA., Finlan M; Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Zhou QC; Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Iasonos A; Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Zivanovic O; Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Obstetrics & Gynecology, Weill Cornell Medical College, New York, New York, USA., Sonoda Y; Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Obstetrics & Gynecology, Weill Cornell Medical College, New York, New York, USA., Chi DS; Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Obstetrics & Gynecology, Weill Cornell Medical College, New York, New York, USA., Long Roche K; Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Obstetrics & Gynecology, Weill Cornell Medical College, New York, New York, USA., Jewell E; Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Obstetrics & Gynecology, Weill Cornell Medical College, New York, New York, USA., Tew WP; Medicine, Weill Cornell Medical College, New York, New York, USA.; Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., O'Cearbhaill RE; Medicine, Weill Cornell Medical College, New York, New York, USA.; Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Cohen S; Medicine, Weill Cornell Medical College, New York, New York, USA.; Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Makker V; Medicine, Weill Cornell Medical College, New York, New York, USA.; Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Liu YL; Medicine, Weill Cornell Medical College, New York, New York, USA.; Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Friedman CF; Medicine, Weill Cornell Medical College, New York, New York, USA.; Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kyi C; Medicine, Weill Cornell Medical College, New York, New York, USA.; Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Zamarin D; Medicine, Weill Cornell Medical College, New York, New York, USA.; Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Gardner G; Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA gardnerg@mskcc.org.; Obstetrics & Gynecology, Weill Cornell Medical College, New York, New York, USA.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Apr 01; Vol. 34 (4), pp. 594-601. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Genital Neoplasms, Female*/radiotherapy , Brain Neoplasms*, Humans ; Female ; Immune Checkpoint Inhibitors ; Combined Modality Therapy ; Progression-Free Survival ; Retrospective Studies

المؤلفون: Friedman CF; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: friedmac@mskcc.org., D'Souza A; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Bello Roufai D; Department of Medical Oncology, Institut Curie, Saint Cloud, France., Tinker AV; BC Cancer-Vancouver, Vancouver, British Columbia, Canada., de Miguel M; Ramón y Cajal University Hospital, Madrid, Spain., Gambardella V; Hospital Clínico Universitario de Valencia, Valencia, Spain., Goldman J; The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Loi S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Melisko ME; UCSF Early Phase Investigational Therapeutics, University of California San Francisco, San Francisco, CA, USA., Oaknin A; Gynecological Cancer Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain., Spanggaard I; University Hospital, Rigshospitalet, Copenhagen, Denmark., Shapiro GI; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., ElNaggar AC; West Cancer Center and Research Institute, Memphis, TN, USA., Panni S; Cremona Hospital, Cremona, Italy., Ravichandran V; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Frazier AL; Puma Biotechnology Inc, Los Angeles, CA, USA., DiPrimeo D; Puma Biotechnology Inc, Los Angeles, CA, USA., Eli LD; Puma Biotechnology Inc, Los Angeles, CA, USA., Solit DB; Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Feb; Vol. 181, pp. 162-169. Date of Electronic Publication: 2024 Jan 11.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/drug therapy , Uterine Cervical Neoplasms*/genetics , Quinolines*/adverse effects , Adenocarcinoma*/drug therapy, Humans ; Female ; Receptor, ErbB-2/genetics ; Treatment Outcome ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Diarrhea/chemically induced ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Hainsworth JD; Sarah Cannon Research Institute, Nashville, TN.; Tennessee Oncology, PLLC, Nashville, TN., Bose R; Washington University School of Medicine, St Louis, MO., Burris HA; Sarah Cannon Research Institute, Nashville, TN.; Tennessee Oncology, PLLC, Nashville, TN., Kurzrock R; Medical College of Wisconsin Cancer Center, Milwaukee, WI., Swanton C; Francis Crick Institute, London, United Kingdom.; UCL Hospitals, London, United Kingdom., Friedman CF; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Medical College at Cornell University, New York, NY., Spigel DR; Sarah Cannon Research Institute, Nashville, TN.; Tennessee Oncology, PLLC, Nashville, TN., Szado T; Genentech, Inc, South San Francisco, CA., Schulze K; Genentech, Inc, South San Francisco, CA., Price R; Genentech, Inc, South San Francisco, CA., Malato J; Genentech, Inc, South San Francisco, CA., Lo AA; Genentech, Inc, South San Francisco, CA., Levy J; Genentech, Inc, South San Francisco, CA., Wang Y; Genentech, Inc, South San Francisco, CA., Yu W; Genentech, Inc, South San Francisco, CA., Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, TX.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jan 20; Vol. 42 (3), pp. 258-265. Date of Electronic Publication: 2023 Oct 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Proto-Oncogene Proteins p21(ras)*/metabolism , Neoplasms*/drug therapy , Neoplasms*/genetics , Neoplasms*/pathology , Antibodies, Monoclonal, Humanized*, Adult ; Humans ; Trastuzumab/adverse effects ; Receptor, ErbB-2/metabolism ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Friedman CF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York., Ravichandran V; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Miller K; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Vanderbilt C; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Zhou Q; Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Iasonos A; Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Vivek M; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Mishra P; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Leitao MM Jr; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of OB/GYN, Weill Cornell Medical College, New York, New York., Broach V; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of OB/GYN, Weill Cornell Medical College, New York, New York., Sonoda Y; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of OB/GYN, Weill Cornell Medical College, New York, New York., Kyi C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York., Zamarin D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York., O'Cearbhaill RE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York., Konner J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York., Berger MF; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Momeni Boroujeni A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Park KJ; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York., Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 14; Vol. 29 (22), pp. 4660-4668.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/drug therapy , Uterine Cervical Neoplasms*/genetics, Female ; Humans ; Prospective Studies ; Genomics ; Mutation ; Microsatellite Instability ; Biomarkers, Tumor/genetics ; High-Throughput Nucleotide Sequencing/methods

المؤلفون: Rios-Doria E; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Momeni-Boroujeni A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Friedman CF; Gynecologic Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA., Selenica P; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhou Q; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu M; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marra A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leitao MM Jr; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Surgery, Weil Cornell Medical College, New York, NY, USA., Iasonos A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alektiar KM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sonoda Y; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Surgery, Weil Cornell Medical College, New York, NY, USA., Makker V; Gynecologic Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA., Jewell E; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Surgery, Weil Cornell Medical College, New York, NY, USA., Liu Y; Gynecologic Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA., Chi D; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Surgery, Weil Cornell Medical College, New York, NY, USA., Zamarin D; Gynecologic Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA., Abu-Rustum NR; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Surgery, Weil Cornell Medical College, New York, NY, USA., Aghajanian C; Gynecologic Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA., Mueller JJ; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Surgery, Weil Cornell Medical College, New York, NY, USA., Ellenson LH; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: Weigeltb@mskcc.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2023 Jul; Vol. 174, pp. 262-272. Date of Electronic Publication: 2023 May 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Suppressor Protein p53*/genetics , Endometrial Neoplasms*/genetics , Endometrial Neoplasms*/pathology, Female ; Humans ; Immunohistochemistry ; Retrospective Studies ; Prognosis ; Mutation

المؤلفون: Disis ML; Cancer Vaccine Institute, University of Washington, Seattle, Washington, USA., Adams SF; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA., Bajpai J; Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Butler MO; Department of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Curiel T; Dartmouth-Hitchcock's Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, New Hampshire, USA., Dodt SA; A Cottage for Counseling, Palm City, Florida, USA., Doherty L; Program in Women's Oncology, Women and Infants Hospital of Rhode Island, Providence, Rhode Island, USA., Emens LA; Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Friedman CF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Gatti-Mays M; Pelotonia Institute for Immuno-Oncology, Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA., Geller MA; Department of Obstetrics, Gynecology & Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota, USA., Jazaeri A; Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., John VS; Department of Medical Oncology & Hematology, Northwell Health Cancer Institute, Lake Success, New York, USA., Kurnit KC; University of Chicago Medicine Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA., Liao JB; University of Washington School of Medicine, Seattle, Washington, USA., Mahdi H; Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Mills A; Department of Pathology, University of Virginia Health System, Charlottesville, Virginia, USA., Zsiros E; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA., Odunsi K; The University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, USA odunsia@bsd.uchicago.edu.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jun; Vol. 11 (6).

نوع المنشور: Practice Guideline; Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Genital Neoplasms, Female*/therapy , Uterine Cervical Neoplasms*/etiology, Female ; Humans ; Immunotherapy ; Quality of Life ; Treatment Outcome